Evaluation of 68Ga-labeled iNGR peptide with tumor-penetrating motif for microPET imaging of CD13-positive tumor xenografts
Evaluation of 68Ga-labeled iNGR peptide with tumor-penetrating motif for microPET imaging of CD13-positive tumor xenografts
复制标题
评估具有肿瘤穿透基序的 68Ga 标记 iNGR 肽用于 CD13 阳性肿瘤异种移植物的 microPET 成像。
DOI:
10.1007/s13277-016-5068-0
复制
发表时间:
2016-09-01
期刊:
影响因子:
--
通讯作者:
Wang, Jing
中科院分区:
文献类型:
--
作者:
Zhao, Mingxuan;Yang, Weidong;Wang, Jing
The aim of the study is to evaluate the efficacy of Ga-68-labeled iNGR, containing Asn-Gly-Arg (NGR) homing sequence and CendR (R/KXXR/K) penetrating motif, as a new molecular probe for microPET imaging of CD13-positive xenografts. The synthesized iNGR and NGR peptides were conjugated with DOTA and then labeled with Ga-68. Ga-68-iNGR and Ga-68-NGR were compared in the performance of the in vitro stability, partition coefficient, binding affinity, cell uptake analysis, in vivo microPET imaging, and biodistribution studies in CD13-positive HT-1080 and CD13-negative HT-29 cell lines. The in vitro results revealed that both probes exhibited high radiochemical purity and stability, and no significant difference between two probes was observed in terms of the binding affinity to CD13. In vivo microPET/CT imaging showed that the uptake of Ga-68-iNGR in HT-1080 tumor was significantly higher than that of Ga-68-NGR. Moreover, tumor Ga-68-iNGR uptake could be completely blocked by cold NGR and partially blocked by neutralizing NRP-1 antibody. We concluded that Ga-68-iNGR has a higher tumor uptake and better tumor retention than Ga-68-NGR through NRP-1, indicating that CendR motif modification is a promising method for improving NGR peptide performance.